Results 231 to 240 of about 53,280 (246)

Tofacitinib treatment for refractory autoimmune encephalitis

Epilepsia, 2021
Yoonhyuk Jang, Woo-Jin Lee, Han Sang Lee   +2 more
exaly  

Tofacitinib

Reactions Weekly, 2017
  +4 more sources

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Lancet, The, 2017
Liza Takiya, Josef S Smolen, Maureen Rischmueller   +2 more
exaly  

Impact of tofacitinib treatment on human B-cells in vitro and in vivo

Journal of Autoimmunity, 2017
Marta Rizzi, Julian Staniek, Arianna Troilo   +2 more
exaly  

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience

Therapeutic Advances in Gastroenterology, 2019
Ferdinando D´Amico, Tommaso Lorenzo Parigi, Gionata Fiorino   +2 more
exaly  

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

Lancet, The, 2015
Hervé Bachelez, P C M Van De Kerkhof, A A Kubanov   +2 more
exaly  

Systematic Review of Tofacitinib: A New Drug for the Management of Rheumatoid Arthritis

Clinical Therapeutics, 2014
Kirandeep Kaur, Sonesh Kalra, Sandeep Kaushal   +2 more
exaly  

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib

Inflammatory Bowel Diseases, 2018
Kevin L Winthrop, Severine Vermeire, Millie D Long   +2 more
exaly  

The off-label uses profile of tofacitinib in systemic rheumatic diseases

International Immunopharmacology, 2020
Zichu Zhao, Cong Ye, Lingli Dong
exaly  

Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies

International Journal of Rheumatic Diseases, 2016
Roy Fleischmann, Joel M Kremer, Yoshiya Tanaka   +2 more
exaly